T. Rowe Price Associates’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-258
| Closed | -$35K | – | 2969 |
|
|
2022
Q3 | $35K | Hold |
258
| – | – | ﹤0.01% | 2872 |
|
|
2022
Q2 | $73K | Hold |
258
| – | – | ﹤0.01% | 2809 |
|
|
2022
Q1 | $85K | Sell |
258
-51
| -17% | -$16.8K | ﹤0.01% | 2864 |
|
|
2021
Q4 | $166K | Buy |
309
+94
| +44% | +$50.5K | ﹤0.01% | 2794 |
|
|
2021
Q3 | $140K | Hold |
215
| – | – | ﹤0.01% | 2778 |
|
|
2021
Q2 | $214K | Hold |
215
| – | – | ﹤0.01% | 2700 |
|
|
2021
Q1 | $290K | Buy |
+215
| New | +$290K | ﹤0.01% | 2573 |
|